KARA DAVIS: Open Payments
NPI 1760140107 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 26 payments from 13 companies in 2025. Trend: 2023 $178 · 2024 $576 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $66 |
| Lilly USA, LLC | 3 | $56 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| PFIZER INC. | 3 | $46 |
| Amgen Inc. | 3 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| Medtronic, Inc. | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
Products named: Wegovy, VOQUEZNA, GARDASIL 9, TRELEGY ELLIPTA, SYNCHROMEDII, PREVNAR 20, OTEZLA, Kerendia.
Industry payments across KY — which companies pay providers there.
